News Release

Herpes zoster vaccination and dementia occurrence

JAMA

Peer-Reviewed Publication

JAMA Network

About The Study: By taking advantage of a quasi-experiment and corroborating findings from Wales in a different population, this study provides evidence of the potential benefits of herpes zoster vaccination for dementia that is more likely to be causal than that of more commonly conducted associational studies.

Corresponding Author: To contact the corresponding author, Pascal Geldsetzer, ScD, MBChB, MPH, email pgeldsetzer@stanford.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2025.5013)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: This study is being presented at the World Vaccine Congress.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.5013?guestAccessKey=f9b03e5d-4caa-4a0c-a7cf-bdbe9c25154a&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042325


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.